The relevance of preferentially expressed antigen of melanoma (PRAME) as a marker of disease activity and prognosis in acute promyelocytic leukemia.

scientific article

The relevance of preferentially expressed antigen of melanoma (PRAME) as a marker of disease activity and prognosis in acute promyelocytic leukemia. is …
instance of (P31):
scholarly articleQ13442814

External links are
P356DOI10.3324/HAEMATOL.13214
P698PubMed publication ID18815192
P5875ResearchGate publication ID23278663

P50authorMarcos González DíazQ5996580
María Jesús PeñarrubiaQ23601347
Ramón García-SanzQ37830539
Miguel AlcocebaQ42123633
María E SarasqueteQ58254875
Teresa BernalQ88763414
Ana BalanzateguiQ114532980
José Antonio QueizánQ117264972
P2093author name stringFernando Ramos
Pilar Giraldo
Jesús F San Miguel
Carlos Santamaría
María Carmen Chillón
P433issue12
P1104number of pages9
P304page(s)1797-1805
P577publication date2008-09-24
P1433published inHaematologicaQ5638209
P1476titleThe relevance of preferentially expressed antigen of melanoma (PRAME) as a marker of disease activity and prognosis in acute promyelocytic leukemia.
P478volume93